Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Lanosterol synthase | ||
Ligand | BDBM50394832 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_860118 (CHEMBL2168444) | ||
IC50 | 28.7±n/a nM | ||
Citation | Staedler, D; Chapuis-Bernasconi, C; Dehmlow, H; Fischer, H; Juillerat-Jeanneret, L; Aebi, JD Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells. J Med Chem55:4990-5002 (2012) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Lanosterol synthase | |||
Name: | Lanosterol synthase | ||
Synonyms: | 2,3-epoxysqualene--lanosterol cyclase | LSS | LSS_HUMAN | OSC | Oxidosqualene--lanosterol cyclase | ||
Type: | PROTEIN | ||
Mol. Mass.: | 83309.32 | ||
Organism: | Homo sapiens (Human) | ||
Description: | ChEMBL_11231 | ||
Residue: | 732 | ||
Sequence: |
| ||
BDBM50394832 | |||
n/a | |||
Name | BDBM50394832 | ||
Synonyms: | CHEMBL2164238 | ||
Type | Small organic molecule | ||
Emp. Form. | C22H31ClN2O4 | ||
Mol. Mass. | 422.946 | ||
SMILES | CN(CC[C@H]1CC[C@@H](CC1)C(=O)N1CCC(O)CC1)C(=O)Oc1ccc(Cl)cc1 |r,wU:7.10,wD:4.3,(42.05,-39.41,;42.04,-40.95,;40.7,-41.71,;39.38,-40.93,;38.04,-41.69,;36.71,-40.92,;35.36,-41.68,;35.37,-43.22,;36.7,-44,;38.03,-43.23,;34.04,-43.99,;34.03,-45.53,;32.7,-43.21,;31.37,-43.98,;30.05,-43.21,;30.05,-41.67,;28.71,-40.91,;31.37,-40.9,;32.7,-41.67,;43.37,-41.72,;43.36,-43.26,;44.71,-40.96,;46.04,-41.74,;46.02,-43.28,;47.35,-44.05,;48.69,-43.29,;50.02,-44.07,;48.69,-41.74,;47.36,-40.97,)| | ||
Structure |